DMAC
DiaMedica Therapeutics Inc. Common StockData: 2026-09-25
Quick Stats
Sep 25, 202632.0
AI Score
AVOID NEW MONEY1.51
Volume Ratio
Nov 11, 2026
Next Earnings
14
+ve Days (30d)
12
-ve Days (30d)
DMAC Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
DMAC Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
DMAC Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DMAC Daily Out of Money Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DMAC Daily In the Money Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DMAC Most Active Options by Volume(near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DMAC Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DMAC Stock Summary
Last updated Sep 25, 2026
DMAC is currently trading at $7.94, positioned above its 200-day moving average of $7.12, indicating a long-term uptrend. The stock has a 52-week range of $5.245 to $10.4195.
Technical Analysis: The 50-day moving average stands at $6.77, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 72.125, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.171, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates DMAC at 32.0/100 with a AVOID NEW MONEY recommendation.
DMAC (DiaMedica Therapeutics Inc. Common Stock) Indicators
Last updated Sep 25, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 72.125 |
| CMF (20) | 0.171 |
| ROC (10) | 22.72 |
| ADX (14) | 27.816 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.272 |
| AROONOSC (14) | 78.571 |
| WILLAMS %R (14) | -3.529 |
| MFI (14) | 72.852 |
DMAC Candlestick Patterns
No validated candlestick patterns fired for DMAC in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
DiaMedica Therapeutics Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.
DMAC Moving Averages Analysis
DiaMedica Therapeutics Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 25, 2026
DiaMedica Therapeutics Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 25, 2026
DMAC (DiaMedica Therapeutics Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 25, 2026
| Days | MA |
|---|---|
| 10 | 7.18 |
| 20 | 6.85 |
| 30 | 6.79 |
| 50 | 6.77 |
| 100 | 6.57 |
| 200 | 7.12 |
DMAC Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 422.2 million |
| Earnings/Share ($) | -0.72 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.8125 |
| EPS Estimate Next Year ($) | -0.808 |
| WallStreet Target Price ($) | 15.50 |
| Most Recent Quarter |
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.